Preview

Regulatory Research and Medicine Evaluation

Advanced search

Recommendations for the Contents of the “Peptide Mapping” Part of a Product Specification File

https://doi.org/10.30895/1991-2919-2021-11-4-276-277

Abstract

‘Identification. Peptide mapping’ is a necessary part of manufacturers’ product specification files for therapeutic proteins (active ingredients and final products of monoclonal antibodies, filgrastims, erythropoietins). The expert of the Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation provides recommendations for a step-by-step presentation of the test procedure, which will allow applicants to align product specification files for Russian- and foreign-produced medicinal products, help experts to minimise or eliminate the need to request additional information from applicants, and will contribute to timely batch release of medicinal products.

About the Author

O. A. Vaganova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Olga A. Vaganova, Candidate of Pharmaceutical Sciences, Head of the Laboratory of Biotechnological Products



Supplementary files

Review

For citations:


Vaganova O.A. Recommendations for the Contents of the “Peptide Mapping” Part of a Product Specification File. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2021;11(4):276-277. (In Russ.) https://doi.org/10.30895/1991-2919-2021-11-4-276-277

Views: 720


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)